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A B S T R A C T   
Recent advances in high power, pulsed, light emitting diodes (LEDs) have shown potential as fast, robust and 
relatively inexpensive excitation sources for photoacoustic imaging (PAI), yet systematic characterization of 
performance for biomedical imaging is still lacking. We report here technical and biological validation studies of 
a commercial dual-wavelength LED-based PAI and ultrasound system. Phantoms and small animals were used to 
assess temporal precision. In phantom studies, we found high temporal stability of the LED-based PAI system, 
with no significant drift in performance observed during 6 h of operation or over 30 days of repeated mea-
surements. In vivo dual-wavelength imaging was able to map the dynamics of changes in blood oxygenation 
during oxygen-enhanced imaging and reveal the kinetics of indocyanine green contrast agent inflow after 
intravenous administration (Tmax~6 min). Taken together, these studies indicate that LED-based excitation could 
be promising for future application in functional and molecular PAI.   
1. Introduction 
Photoacoustic imaging (PAI) is an exciting new modality for mo-
lecular imaging, which refers to the visualization, characterization and 
measurement of biological processes at the molecular and cellular levels 
in living subjects [1]. PAI reveals optical contrast at high 
spatio-temporal resolution by acoustically detecting optical absorption 
through the photoacoustic effect [2–4]. The unique capability of PAI to 
combine rich optical contrast with high ultrasonic spatial resolution in a 
single modality has proven advantageous for molecular imaging and led 
to adoption in studies ranging from fundamental biological sciences to 
clinical translational applications [5–8]. By performing PAI at multiple 
wavelengths, it is possible to resolve the selective light absorption of 
endogenous molecular imaging chromophores, such as hemoglobin, 
lipids and melanin, from those administered as exogenous contrast 
agents for both functional and molecular imaging [9]. Inspired by 
progress in other fields, recent studies in PAI have demonstrated clear 
capability for functional imaging, using oxygen-enhanced and 
dynamic-contrast-enhanced approaches in particular [10–12], as well as 
for targeted molecular imaging, exploiting state-of-the-art 
nanostructures and encapsulation designs [13–15]. 
One challenge that remains for widespread uptake of PAI is the 
reliance on relatively slow, fragile and expensive nanosecond pulsed 
lasers as excitation sources. While lasers can provide high pulse exci-
tation power along with tunable output wavelengths, they typically 
result in bulky systems that require regular maintenance and their 
biomedical application requires compliance with laser safety standards 
for both the subject under study and also for the environment in which 
the study is undertaken. Furthermore, some contrasts agents including 
plasmonic nanoparticles are observed to be less stable when used in 
laser-based PAI systems [16,17]. Advances in solid-state device tech-
nology have resulted in the development of several solutions for rela-
tively fast, robust and low-cost excitation sources for PAI, such as pulsed 
laser diodes (PLDs) and high-power light emitting diodes (LEDs) [18]. In 
particular, commercial LED-based PAI devices have proven attractive 
for a range of in vivo molecular imaging applications, from stem cell 
imaging to evaluation of arthritis, and interventional procedures 
[18–27]. Such early promise suggests LED-based PAI has the potential to 
be adopted as a preclinical and clinical imaging tool, yet systems need to 
undergo technical and biological validation prior to being used for 
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longitudinal studies in the biomedical setting [28]. Prior work has 
focused on evaluating the LED beam profile, available resolution and 
penetration depth for imaging, as well as contrast agent sensitivity but as 
yet, temporal precision for performing functional and molecular imag-
ing over time has not been evaluated. 
Here, we report technical and biological validation studies of a dual- 
wavelength LED-based PAI and ultrasound imaging system that has the 
potential to perform real-time in vivo imaging. Our studies aimed to 
evaluate the temporal precision of the system for application to dynamic 
and longitudinal in vivo imaging. Evaluation of precision was performed 
in phantoms and in vivo. Measurements were made in tissue-mimicking 
phantoms to independently assess the impact of system variables on 
precision, including sample positioning and frame averaging. Temporal 
variation was assessed by repeated measurements over minutes, hours 
and days in the phantoms. In vivo studies were then made using small 
animals for biological validation of the system using both oxygen- 
enhanced and dynamic contrast-enhanced imaging. 
2. Materials and methods 
2.1. LED-based photoacoustic imaging 
A commercial LED-based photoacoustic (PA) and ultrasound (US) 
imaging system (Acoustic X, CYBERDYNE INC., Japan) was used in this 
study. The system performs interleaved PA and US (planewave or line- 
by-line scan) measurements at video rate using LED arrays as the exci-
tation sources for PAI. In this work, we used a combinational two- 
wavelength LED array operating at 750 and 850 nm. Each LED array 
consists of 120 elements, in which first and third rows are embedded 
with 850 nm LED elements (36 elements in a row) and second and fourth 
rows with 750 nm elements (24 elements per row). Energy per pulse is 
50 μJ, and 100 μJ for 750 nm and 850 nm respectively and the LEDs 
were driven at their maximum pulse repetition rate (PRR) of 4 KHz [22, 
29]. A pair of LED arrays were fixed on both sides of a linear array US 
probe [22], which covers the whole aperture of the linear array US probe 
(38.4 mm) and provides an illumination area of 50 mm × 7 mm onto 
the sample surface. The illumination pulse duration (full width at half 
maximum) of LED light is tunable and can be varied from 30 to 100 ns; 
70 ns was used in this study. 
2.2. Ultrasound detection and processing 
US detection was performed with a linear-array PZT-based probe 
composed of 128 elements, each with a transverse aperture of 5 mm and 
a pitch of 0.315 mm. The array has a central frequency of 7 MHz and a 
measured − 6 dB bandwidth of 80 %. The array incorporates an acoustic 
lens to focus the US in the elevational plane at about 20 mm. For LED- 
based PAI, raw radiofrequency (RF) data from all US elements are ac-
quired at sampling rates of 40 MHz and 20 MHz respectively for US and 
PA imaging and transferred to the computer graphical processing unit 
board using USB 3.0 interface. Acquired data (US and PA) are recon-
structed using a system integrated Fourier-domain based reconstruction 
algorithm [30] for real-time display. The high pulse repetition rate (4 
KHz) of the LED excitation sources affords the ability to perform aver-
aging to enhance the signal to noise ratio (SNR) while maintaining 
real-time frame rates. When frame averaging of 128 frames is per-
formed, the display frame rate is 30 Hz; this reduces to 1.5 Hz when 
2560 photoacoustic frames are averaged. The frame rate was controlled 
in real-time based on the SNR obtained during experiments, except in 
experiments where the SNR was the variable under test. After each 
measurement, raw RF data (PA and US) were saved for further offline 
processing. 
2.3. Gantry for evaluating precision of LED-based photoacoustic imaging 
To perform precision evaluations in phantoms and in vivo, a gantry 
was designed to mount the handheld ultrasound probe with LED arrays, 
minimizing the influence of the human operator on the studies (Fig. 1A, 
B). The gantry was composed of a motorized laboratory jack for z 
positioning (MLJ150/M, Thorlabs) and two translation stages for x,y 
positioning (OSMS20-8, Sigmakoki, Corp). The probe was mounted 
within a custom holder and attached to the manual (x,y,z) positioning 
stages. A custom acrylic water bath was mounted onto the same 
breadboard (MB3045/M, Thorlabs, Inc.) containing an aluminum 
phantom holder for phantom imaging; a second custom water bath 
(fabricated using acrylic side walls and polyethylene membrane base) 
and temperature-maintained animal bed with infrared heat pad were 
used for in vivo imaging (Fig. 1C, D). Once mounted in either setup, the 
probe could be raised and lowered onto the imaged samples using the 
motorized laboratory jack. 
2.4. Precision evaluation in phantoms 
Polyvinyl chloride plastisol (PVCP) phantom bulk material was used 
to fabricate a stable phantom used for precision evaluation. The me-
chanical, optical and ultrasound properties of PVCP have been reported 
previously [31–33]. Briefly, the phantom base material was composed of 
commercial polyvinyl chloride plastisol (PVCP; M-F Manufacturing Co, 
USA) with black plastic color (BPC; M-F Manufacturing Co, USA) to 
provide an absorption coefficient μa of 0.05 cm− 1 and titanium oxide 
(TiO2) powder (232033; Sigma-Aldrich, UK) to give a reduced scattering 
coefficient μ′s of 5 cm− 1 based on our prior work [31]. The base material 
mixture was heated under vacuum until the phase transition was com-
plete and poured into a custom phantom mold in which cylindrical holes 
of 3 mm diameter were formed at ~1.2 cm below the phantom surface. 
These cylindrical holes were used to place sealed thin-walled plastic 
straws containing solutions of the light absorbing dye nigrosin (198285; 
Merck, UK) at 0.5 mg mL− 1 to form the target inclusions for precision 
evaluation or the fluorescent dye indocyanine green (ICG, I2633; 
Sigma-Aldrich, UK) at a range of concentrations to test sensitivity prior 
to in vivo imaging. 
The phantom mold was mounted into the phantom holder, which 
ensured repeated positioning, and placed into the custom water bath at 
room temperature. Phantoms were allowed to attain temperature 
equilibrium with the water bath before any imaging was performed. 
Following temperature equilibration of the phantom, images were ac-
quired from the target inclusions at 750 nm and 850 nm. The stability of 
the system was assessed over 180 min and the repeatability in longitu-
dinal studies was measured over the course of 6 h, 1 day and 1 month. 
The impact of averaging on signal to noise ratio (SNR) and signal to 
background ratio (SBR) was also assessed using the same phantom. 
2.5. Precision evaluation in vivo 
Procedures in small animals were carried out in accordance with 
project (70-8214) and personal licenses (IFBB827BC) issued under the 
United Kingdom Animals (Scientific Procedures) Act, 1986. The pro-
cedures were reviewed by the Animal Welfare and Ethical Review Board 
at the CRUK Cambridge Institute under compliance form number 
CFSB1232V2. Healthy female BALB/c nude mice aged between 8 and 12 
weeks were housed in techniplast green line IVC cages with APB6 
bedding on 12 h on/off light/dark cycle (7a.m.–7p.m.). 
For imaging in living subjects, evaluation of precision was made 
separately across oxygen enhanced and dynamic contrast enhanced 
parameters, according to the following standard operating procedure. 
Briefly, mice were anaesthetized using <2.5 % isoflurane in 100 % ox-
ygen and placed on a heat pad. Administration of contrast agents was 
carried out using a catheter (home-made with 30 G needle) placed into 
the tail vein and fixed in place using tissue glue (TS1050071 F; Tissue-
Seal). The respiratory rate of the animals was maintained within range 
70–80 b.p.m. by modulating the isoflurane concentration (1.5–2.5 % 
isoflurane concentration) as required during the entire scan. Mice were 
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placed supine over a far infrared heating pad (Kent Scientific Corp, 
USA). The far infrared heating pad ensured efficient and safe warming of 
the animal throughout the entire imaging procedure. 
The LED-based PA/US probe was placed inside a custom water bath 
made with a layer of flexible polyethylene membrane forming the base 
of the imaging chamber. A thin layer of clear ultrasound gel (Aqua-
sonics, Parker Laboratories Inc, USA) was applied over the skin of the 
mouse to provide acoustic coupling between the animal body and the 
polyethylene membrane of the imaging chamber. Imaging was per-
formed in a single slice centered on the liver. Oxygen enhanced PA 
studies were performed at 750 nm and 850 nm excitation (0.75 frames 
per second, 5320 frame averages) with breathing gas modulated be-
tween medical air (21 % oxygen) and pure oxygen (100 % oxygen) using 
separate flow meters. The combination LED array (750 nm and 850 nm) 
allows wavelength switching at a repetition rate of 4 KHz, so frame 
averaging could be performed to improve the SNR without compro-
mising the image frame rate. Animals (n = 2) were subjected to 3 
modulation cycles (medical air to pure oxygen) of breathing air. One 
week later, dynamic contrast-enhanced studies were performed in the 
same animals. ICG was chosen for these studies as it is an FDA approved 
and water-soluble dye that has been widely used for a variety of clinical 
endpoints, such as hepatic function [34] and is commonly used in PAI 
studies. Mice were initially allowed to stabilize their physiology for 
10 min. After 30 s of continuous imaging at 750 nm excitation (0.75 
frames per second, 5320 times averaging) to establish the baseline PA 
signal, ICG (48 nmol, selected based on prior studies linking in vitro and 
in vivo detectability [28,35]) was administered intravenously through 
the tail vein catheter. PAI image acquisition at 750 nm excitation was 
continued for a further 15 min to extract the dynamics and signal 
enhancement curve. 
2.6. Image and statistical analysis 
Images were reconstructed offline as mentioned above using a pre-
viously reported Fourier-domain reconstruction algorithm [30] and 
analyzed in MATLAB 2017b (Mathworks) using custom software and the 
envelope of images (PA and US) were plotted in linear amplitude scale. 
Image reconstruction assumed a constant speed of sound in the medium, 
being 1450 ms− 1 for phantom studies (based on the sound speed in 
PVCP) and 1540 ms− 1 for animal experiments (based on the soft tissue 
average). The use of a single sound speed may impact the depth of 
reconstructed features in the case of inhomogeneous speed of sound 
inside the test object. Pixel size in the axial and lateral directions of both 
PA and US images were 40 μm and 315 μm respectively. Images were 
normalized by the pulse energy. Regions of interest (ROI) were drawn 
manually around the targets of interest and mean pixel intensity (MPI) 
values were extracted from the ROIs. For phantom studies, images ob-
tained at 750 nm and 850 nm excitation wavelengths were used with the 
position and size of signal and background ROIs set identically across all 
data sets. SNR was calculated as the ratio of the mean of the signal ROI to 
the standard deviation of the background ROI. Signal-to-background 
ratio (SBR) was calculated as the ratio of the mean of the signal ROI 
to the mean of the background ROI. 
For small animal imaging studies, ROIs were drawn around the liver 
region of each mouse. Dual wavelength (750 nm and 850 nm) images 
were used to infer the relative oxygenation of the hemoglobin in the 
tissue during the OE experiment. PA-based oximetry relies on the 
spectroscopic differences between oxyhemoglobin (HbO2) and deoxy-
hemoglobin (Hb). Since HbO2 and Hb are the dominant absorbing 
compounds in a nude mouse in the spectral region under study, the PA 
measurements of the animal at 850 nm and 750 nm respectively were 
considered sufficient to evaluate relative oxygenation without 
compensating for the local fluence [36]. Since PAI is not able to measure 
absolute SO2 without an accurate knowledge of local optical energy 
distribution, the SO2 metric used in this study is only relative and we 
denote this as SO2PAI; the average SO2PAI for medical air and oxygen 
breathing periods are denoted as SO2PAI (Air) and SO2PAI (Oxygen) 
respectively. SO2PAI values for each pixel were calculated by taking the 
ratio of the 850 nm image to the sum of that from 750 nm and 850 nm. 
For the dynamic contrast enhanced experiment, the 750 nm images 
were analyzed and the extracted metrics included: time to half 
maximum (T1/2), which gives the time taken for the signal to rise from 
baseline to 50 % of maximum intensity; and time to maximum (Tmax), 
the time taken for the signal to rise from baseline to the maximum 
intensity. 
Coefficients of variation (COV) were calculated from the raw MPI 
values extracted from the ROIs as the ratio of the standard deviation to 
the mean and expressed as a percentage. Uncertainty on mean values is 
represented by the standard error unless otherwise stated. Statistical 
analysis was performed in Origin (OriginLab Corp.). Linear regression 
analysis was performed in Origin and P-value < 0.05 was considered as 
statistically significant. 
Fig. 1. Schematic of gantry and custom 
water baths for LED-based photoacoustic 
(PA) and ultrasound (US) imaging precision 
evaluation. (A) 3D gantry enables careful 
probe positioning with (x,y,z) control in a 
custom water bath. (B) For phantom imaging, a 
specific phantom holder was placed within the 
custom water bath from above. (C) For animal 
imaging, the custom water bath was placed 
above the animal, which was maintained on a 
heat pat underneath the holder and coupled 
with a polyethylene membrane (D).   
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3. Results 
3.1. Longitudinal imaging in a stable phantom showed high precision of 
the LED-based PAI system 
We first evaluated the longitudinal imaging performance of the 
system in phantoms (Fig. 2A) over 180 min (without replacement), 6 h 
(with and without replacement) and 30 days (with replacement) using 
the 750/850 nm combinational LED array. The temporal stability of the 
LED-based photoacoustic imaging system for over 180 min in phantoms 
was found to be excellent: the slopes of the linear fits to the data ac-
quired over 180 min were not statistically different from zero, indicating 
negligible system drift (Fig. 2B). Further, the extended study over 30 
days resulted in coefficients of variation (COVs) of only 7.0 % and 5.8 % 
respectively for 750 nm and 850 nm excitation wavelengths (Fig. 2C) 
with no significant system drift. Within the 6 h study, we examined the 
influence of sample replacement on the data, by removing and replacing 
the phantom in one study (Fig. 2D), and leaving it within the imaging 
system in a second (Fig. 2E). The COVs over 6 h at 750 nm and 850 nm 
were found to be 1.9 % and 1.2 % respectively with replacement and 1.5 
% and 1.2 % respectively without replacement. No significant system 
drift was observed in the mean pixel intensity extracted from the signal 
ROI during the course of 6 h. 
3.2. Enhancement of image quality is observed through averaging LED 
pulses while maintaining real-time imaging 
We then confirmed the impact of frame averaging on the measured 
image signal-to-noise ratio (SNR) and signal-to-background ratio (SBR) 
using the same phantom. As expected, frame averaging results in an 
increase of image SNR and SBR at both 750 nm (Fig. 3A and B) and 
850 nm (Fig. 3C and D). We noted a slight dip in performance for the 
850 nm LED at around 25,000 averages, which may be due to an 
unanticipated source for experimental error in our data given that the 
error bars are contained within the symbols for this plot. In both cases, a 
threshold above which further averaging did not substantially improve 
performance was reached: for 750 nm this occurred at 20,000 averages 
whereas for 850 nm this was already the case at 10,000 averages. At this 
level of averaging (i.e. maximal SNR and SBR) the frame rate would be 
0.1 and 0.2 Hz respectively at 750 nm and 850 nm, yet operation could 
be maintained at 0.75 Hz with 5320 frame averaging, which still rep-
resents an increase of 35-fold in SNR, 16-fold in SBR and 280-fold in 
SNR, 265-fold in SBR compared to no averaging at 750 nm and 850 nm 
respectively. 
3.3. The LED-based system can perform oxygen enhanced PAI 
Following our phantom studies, we commenced studies to test tem-
poral precision of the readout provided by LED-based PAI in oxygen 
enhanced hemoglobin imaging. We selected 2660 averages for imaging 
at 0.75 Hz at both wavelengths based on our phantom experiments, 
which was reasonable based on the anticipated kinetics of the data we 
would be recording. Dynamic data was recorded while the mice 
breathed either medical air (Movie 1) or 100 % oxygen (Movie 2). By 
extracting the data available from dual wavelength imaging (Hb at 
750 nm and HbO2 at 850 nm), SO2PAI was estimated across multiple 
breathing cycles exploiting the high temporal resolution of the system. 
The results allowed us to evaluate the precision with which LED-based 
PAI could extract changes in oxygen saturation in the liver. SO2PAI 
maps of the liver showed clear variations in SO2PAI levels during oxygen 
enhancement, while the mouse was breathing either medical air or pure 
oxygen (Fig. 4A). The dynamics of SO2PAI over time under multiple 
breathing cycles (Fig. 4B) were then extracted for all mice (Table 1). 
These dynamic studies yielded COV values of 2.9 % for SO2PAI (Air) and 
3.5 % for SO2PAI (Oxygen) within same mouse and 7.6 % for SO2PAI (Air) 
and 10 % for SO2PAI (Oxygen) across replicates (n = 2). The consistency 
of the change in blood oxygenation levels (ΔSO2) under different 
breathing cycles indicates that, as with other PAI studies [10,29], a high 
precision is available for the system in measuring changes in blood 
oxygenation (within one mouse) and with studies across multiple mice, 
indicates the inherent biological variation between living subjects. 
3.4. Dynamic contrast enhanced imaging detects uptake of indocyanine 
green in the liver 
Finally, we performed in vivo LED-based PAI in the liver region after 
administration of indocyanine green, to assess the ability of the system 
to monitor the uptake of exogenous contrast agents. We first placed 
solutions of ICG into the stable phantom and determined the limit of 
detection for ICG to be 5μM at 1 cm depth in the phantom. We then 
Fig. 2. LED-based PAI exhibits high temporal precision in phantom imaging. (A) Photo (top) and PA image (bottom) of the PVCP phantom used for stability 
studies. Target inclusions are indicated with arrows. Mean pixel intensity values extracted from regions of interest (exemplars shown in dotted lines in A) were 
examined for continual acquisition over 180 min (B), repeated acquisitions over 30 days (C) and over 6 h with (D) and without (E) replacement. Replacement 
indicates removal of the phantom from the imaging system in between measurements. Error bars are within the symbols. The gradient of the linear fits to the data for 
the 850 nm LED (black) and 750 nm LED (red) are given within each panel; none of the gradients are significantly non-zero. 
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acquired in vivo PA signals at 750 nm excitation wavelength, which 
clearly showed an increase in the PA signal within the liver from the 
baseline (Fig. 5A) over time following administration of ICG (Fig. 5B). 
The signal enhancement curves (Fig. 5B) gave T1/2 and Tmax values of 
~2.2 min and ~5 min respectively, showing the dynamic mapping of 
the changes in the uptake of indocyanine green and in a close agreement 
with a previously reported study that used a laser-based PAI system 
[35]. 
4. Discussion 
PAI is a rapidly evolving hybrid optical imaging modality that offers 
high spatio-temporal resolution and deep tissue imaging capabilities 
with optical contrast. The combined functional and molecular imaging 
capability of PAI makes it a promising imaging technology for 
biomedical applications, however, the reliance on bulky, expensive and 
fragile pulsed lasers, with their associated safety requirements, has led 
to a demand for more portable and inexpensive LED-based systems. The 
aim of this work was to evaluate the suitability of an LED-based PAI 
system for molecular imaging in small animals by assessing the temporal 
precision of the approach in phantoms and in vivo. 
Data acquired in stable phantoms showed high precision for the LED- 
based PAI system. COVs across both wavelengths studied were found to 
be less than 2 % over 6 h (one day) and less than 7 % over 30 days, 
indicating high potential for longitudinal imaging studies using the 
technology. A similar level of precision has been found in laser-based 
PAI systems and compares well with other modalities for small animal 
imaging [28]. Reflecting on the phantom studies, across all parameters 
tested the factors that made the greatest impact on the signal repeat-
ability were phantom positioning (based on replacement studies) and 
number of averages (based on SNR/SBR studies). Molecular imaging 
capabilities of LED-based PAI were then tested to perform biological 
validation under in vivo conditions. The results of our oxygen enhanced 
study clearly indicated the potential of the system to measure changes in 
blood oxygenation. The ability of the system to perform dynamic 
contrast enhanced studies of the kinetics of exogenously administered 
contrast agents was also assessed. The sensitivity for detection of ICG 
was lower than previously reported for laser-based systems, being 5 μM 
rather than 100 nM at 1 cm depth. Nonetheless, our findings indicate 
that the system is able to detect the dynamics of ICG in vivo and 
encouragingly the results closely match with a previous study conducted 
using laser-based PAI [35]. The implication of our findings is that 
LED-based PAI can operate at high precision for real-time structural, 
functional and molecular imaging, which is important for biomedical 
applications in small animal models. 
Several limitations exist in our study. Firstly, the LED-based PAI 
system under test is designed for handheld operation. To evaluate purely 
the system precision, we designed a custom gantry for application to 
phantoms and small animals, to minimize the influence of probe posi-
tioning and hence operator expertise. Future studies should compare 
these findings to data acquired under handheld conditions with different 
operators, to further assess the influence of these factors. Secondly, data 
acquired at 750 nm and 850 nm were used to evaluate the relative 
oxygenation of the hemoglobin, however, in the absence of fluence 
corrections, spectral coloring effects in tissue at depth were likely to 
have impacted the quantification of oxygenation, hence it being denoted 
in this study as a relative SO2PAI rather than absolute sO2. 
5. Conclusion 
In summary, we performed technical and biological validation 
studies of a dual-wavelength LED-based PA / US imaging system. Our 
studies show that the dual-wavelength imaging capability of the system 
offers excellent precision in phantoms. The system is also capable of 
mapping changes in blood oxygenation levels and uptake of exogenous 
contrast agents. Thus, high power light emitting diodes (LEDs) can serve 
as fast, robust and cheap excitation sources for PAI in vivo based on both 
endogenous and exogenous molecular contrast, yielding a promising 
alternative to laser-based systems in biomedical applications. 
Fig. 3. Impact of frame averaging on image quality in phantoms. Imaging signal-to-noise ratio (SNR) and signal to background ratio (SBR) increase as a function 
of the number of frame averages at 750 nm (A,B) and 850 nm (C,D). Error bars are within the symbols. 
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Fig. 4. LED-based PAI is sensitive to an oxygen enhanced breathing gas 
challenge in the liver. (A) PA images obtained from the liver region with the 
mouse breathing either medical air (21 % oxygen) or 100 % oxygen gas. Region 
of interest for quantification shown as a dashed white ellipse. (B) Exemplar 
graph of the extracted SO2PAI over time in one mouse over 3 cycles of oxygen 
enhancement. 
Table 1 
Summary of the dynamics of SO2PAI over time under multiple breathing cycles 
measured from the oxygen challenge studies.  
OE 
Direction 

















Air to O2 0.16 ± 0.01   0.18 ± 0.02   
O2 to Air 0.14 ± 0.02 2.9 3.5 0.23 ± 0.05 7.6 10  
Fig. 5. LED-based PAI shows accumulation of indocyanine green over 
time. (A) PA images obtained from the liver region before (pre-injection) and 
9 min. after (post injection) intravenous administration of indocyanine green. 
Region of interest for quantification shown as a dashed white ellipse. (B) 
Exemplar graph of the normalized mean pixel intensity (MPI) showing the 
dynamic contrast enhancement over time. 
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